Hand-Held Surgical Instruments Market Report 2025

This Hand-Held Surgical Instruments market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The hand-held surgical instruments market size has grown strongly in recent years. It will grow from $7.01 billion in 2024 to $7.6 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to advancements in minimally invasive surgery, aging population, healthcare infrastructure development, surge in chronic diseases, regulatory compliance.

The hand-held surgical instruments market size is expected to see rapid growth in the next few years. It will grow to $11.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote surgery, healthcare expenditure growth, emerging healthcare market, surgical training and skill development. Major trends in the forecast period include surgical robotics integration, eco-friendly and sustainable solutions, advanced materials and coatings, telemedicine and remote surgery, smart and connected instruments.

The surge in the elderly population is a driving force behind the growth of the hand-held surgical instruments market. This demographic, comprising individuals aged 65 and above, is particularly susceptible to illnesses requiring surgical intervention. Surgical instruments play a crucial role in various medical procedures. As of October 2022, the World Health Organization reported that globally, 1 in 6 individuals would be 60 or older by 2030, with an expected rise to 2.1 billion elderly people by 2050. Consequently, the escalating geriatric population is anticipated to significantly boost the hand-held surgical instruments market.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the hand-held surgical instruments market in the future. Chronic diseases refer to enduring health conditions that last for a long time and usually require ongoing medical care. Hand-held surgical instruments are utilized in managing and treating chronic diseases for purposes such as diagnosis and assessment, biopsy and tissue sampling, pain management, and enhancing patient outcomes and quality of life. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by 2050, the number of individuals aged 50 years and older with at least one chronic illness will increase by 99.5%, from 71.522 million in 2020 to 142.66 million. Thus, the rising prevalence of chronic diseases is expected to drive growth in the hand-held surgical instruments market.

Major companies in the handheld surgical devices and equipment market are concentrating on developing innovative solutions, such as knee arthroplasty handheld technology, to meet the rising demand for minimally invasive procedures. This technology includes advanced surgical tools specifically designed for knee replacement surgery, allowing surgeons to accurately and efficiently position implants. These devices incorporate innovations such as real-time imaging and ergonomic designs to enhance precision, shorten surgical time, and promote quicker recovery. For example, in May 2024, Orthalign, a US-based manufacturer of medical equipment, introduced Lantern. This device provides precise, personalized alignment for knee replacement surgeries, addressing the unique anatomical needs of each patient, which is essential for achieving optimal surgical results. Its single-use design improves sterility and reduces the risk of cross-contamination in the operating room. The handheld technology streamlines workflows, making it easy to handle and seamlessly integrate into existing surgical practices. Additionally, it offers functionalities for gap balancing and revision knee surgeries, catering to a broader range of surgical needs beyond standard replacements. Designed for efficiency in ambulatory surgery centers (ASCs), Lantern presents a cost-effective alternative to traditional computer-assisted surgical systems while also decreasing operating room times.

Leading companies in the hand-held surgical instruments market are strategically emphasizing product innovation, exemplified by offerings like the Sunoptic Surgical Light Wand, to fortify their market standing. The Sunoptic Surgical Light Wand is a single-use, sterile, pre-packaged light source designed to illuminate incision sites internally. This innovative solution not only ensures excellent lighting in surgical rooms but also presents an affordable light source for hospitals and clinics. In June 2023, SURE Retractors Inc., a UK-based medical device company, introduced the Sunoptic Surgical Light Wand with an LED light tailored to illuminate deep surgical cavities, eliminating shadows, reducing eye strain during prolonged treatments, and enhancing visibility for surgical procedures. The product boasts a 90-minute guaranteed strong LED light, eliminating the need for additional headlamps or external light sources.

In a strategic move in August 2023, STERIS PLC, an Ireland-based medical equipment provider, successfully acquired surgical instrumentation assets from Becton, Dickinson, and Company, a US-based medical technology company. The acquisition, executed for an undisclosed amount, bolsters STERIS's position by enhancing, complementing, and expanding its product portfolio within the healthcare segment. The acquired assets encompass surgical instrumentation, laparoscopic instrumentation, and sterilization container assets, marking a significant development in STERIS's growth trajectory. Becton, Dickinson, and Company, known for its diverse offerings including medical devices, reagents, and surgical instruments, has strategically contributed to STERIS's product expansion in the competitive healthcare market.

Major companies operating in the hand-held surgical instruments market include Johnson & Johnson, B. Braun Melsungen AG, Medtronic plc, Zimmer Biomet Holdings Inc., KLS Martin Group, Aspen Surgical Products Inc., CooperSurgical Inc., Thompson Surgical Instruments Inc., Becton, Dickinson and Company, Swann-Morton Limited, Peters Surgical SAS, Huaiyin Medical Instruments Co. Ltd., ConMed Corp., Stryker Corporation, Integra LifeSciences Corporation, Smith & Nephew plc, Aesculap AG, Scanlan International Inc., Sklar Surgical Instruments, Symmetry Surgical Inc., Millennium Surgical Corp., Surgipro Inc., Teleflex Incorporated, Wexler Surgical, Grena Ltd., Surgmed Group, Surtex Instruments Ltd., Instrumed International B.V., Surgitrac Instruments UK Limited, Sontec Instruments Inc.

North America was the largest region in the hand-held surgical instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hand-held surgical instruments market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hand-held surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Hand-held surgical instruments, typically crafted from premium stainless steel, encompass a diverse array of sizes, styles, and shapes tailored for various surgical procedures. These instruments are manually operated, held in hand during surgical procedures, and play a crucial role in ensuring precision and efficacy. The extensive range of hand-held surgical instruments includes scalpels, forceps, scissors, and retractors.

The primary product categories within hand-held surgical instruments consist of forceps, retractors, dilators, graspers, scalpels, and other specialized tools. Forceps, for instance, are employed to securely grasp, pull, or hold items, particularly in delicate surgical operations. This versatile two-bladed tool, featuring a handle, serves multiple functions, including managing sterile dressings and gripping tissues. Hand-held surgical instruments find applications in various surgical domains such as neurosurgery, cardiovascular procedures, orthopedics, plastic and reconstructive surgery, obstetrics, and gynecology. These instruments are utilized across a spectrum of healthcare settings, including hospitals, clinics, and ambulatory surgical centers, ensuring their indispensable role in the medical field.

The hand-held surgical instruments market research report is one of a series of new reports that provides hand-held surgical instruments market statistics, including hand-held surgical instruments industry global market size, regional shares, competitors with a hand-held surgical instruments market share, detailed hand-held surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the hand-held surgical instruments industry. This hand-held surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hand-held surgical instruments market consists of sales of cannulas, dermatome, and trocars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.